Published in Vaccine Weekly, October 29th, 2003
"The diversity of autoimmune responses poses a formidable challenge to the development of antigen-specific tolerizing therapy. We developed 'myelin proteome' microarrays to profile the evolution of autoantibody responses in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS)," an international team of scientists reports.
"Increased diversity of autoantibody responses in acute EAE predicted a more severe clinical course," stated William H. Robinson at Stanford University and collaborators throughout the world. "Chronic EAE was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly